Update on the Kelch-like (KLHL) gene family

Human Genomics

Volumn 7, Issue 1, 2013, Pages

  Dhanoa, Bajinder S ^a   Cogliati, Tiziana ^b   Satish, Akhila G ^b   Bruford, Elspeth A ^c   Friedman, James S ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

BTB domain; Cancer; Evolution; Gene family; Gene nomenclature; Kelch domain; KLHL; Mendelian disease; Ubiquitination

Indexed keywords

CULLIN; E3 LIGASE CULLIN 3; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CARRIER PROTEIN; KLHL6 PROTEIN, HUMAN; PROTEIN BINDING;

ARTICLE; DIMERIZATION; EVOLUTION; GENE MUTATION; HUGO GENE NOMENCLATURE; HUMAN; HUMAN CHROMOSOME; KELCH LIKE GENE; MORPHOLOGY; MULTIGENE FAMILY; PHYLOGENY; PROTEIN BINDING; UBIQUITINATION; AMINO ACID SEQUENCE; CLASSIFICATION; GENETIC DISORDER; GENETICS; METABOLISM; NEOPLASM; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; NEOPLASMS;

CARRIER PROTEINS; GENETIC DISEASES, INBORN; HUMANS; MULTIGENE FAMILY; NEOPLASMS; PHYLOGENY; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; REPETITIVE SEQUENCES, AMINO ACID; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; UBIQUITINATION;

EID: 84890307627     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-7-13     Document Type: Article

References (52)

1. Koonin EV, Senkevich TG, Chernos VI: A family of DNA virus genes that consists of fused portions of unrelated cellular genes. Trends Biochem Sci 1992, 17:213-214.
2. Zollman S, Godt D, Prive GG, Couderc JL, Laski FA: The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. Proc Natl Acad Sci USA 1994, 91:10717-10721. (Pubitemid 24329070)
3. Siggs OM, Beutler B: The BTB-ZF transcription factors. Cell Cycle 2012, 11:3358-3369.
4. Bardwell VJ, Treisman R: The POZ domain: a conserved protein-protein interaction motif. Genes Dev 1994, 8:1664-1677. (Pubitemid 24236245)
5. Albagli O, Dhordain P, Deweindt C, Lecocq G, Leprince D: The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ 1995, 6:1193-1198.
6. Perez-Torrado R, Yamada D, Defossez PA: Born to bind: the BTB protein-protein interaction domain. Bioessays 2006, 28:1194-1202. (Pubitemid 44925439)
7. Kang MI, Kobayashi A, Wakabayashi N, Kim SG, Yamamoto M: Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci USA 2004, 101:2046-2051. (Pubitemid 38229012)
8. Minor DL, Lin YF, Mobley BC, Avelar A, Jan YN, Berger JM: The polar T1 interface is linked to conformational changes that open the voltage-gated potassium channel. Cell 2000, 102:657-670.
9. Melnick A, Ahmad KF, Arai S, Polinger A, Ball H, Borden KL, Carlile GW, Prive GG, Licht JD: In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol Cell Biol 2000, 20:6550-6567. (Pubitemid 30650240)
10. Furukawa M, He YJ, Borchers C, Xiong Y: Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat Cell Biol 2003, 5:1001-1007. (Pubitemid 37406914)
11. Xu L, Wei Y, Reboul J, Vaglio P, Shin TH, Vidal M, Elledge SJ, Harper JW: BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature 2003, 425:316-321. (Pubitemid 37158409)
12. Adams J, Kelso R, Cooley L: The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol 2000, 10:17-24. (Pubitemid 30017862)
13. Stogios PJ, Prive GG: The BACK domain in BTB-kelch proteins. Trends Biochem Sci 2004, 29:634-637. (Pubitemid 39491260)
14. Bomont P, Cavalier L, Blondeau F, Ben Hamida C, Belal S, Tazir M, Demir E, Topaloglu H, Korinthenberg R, Tüysüz B, Landrieu P, Hentati F, Koenig M: The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 2000, 26:370-374.
15. Liang XQ, Avraham HK, Jiang S, Avraham S: Genetic alterations of the NRP/B gene are associated with human brain tumors. Oncogene 2004, 23:5890-5900. (Pubitemid 39093533)
16. Yang Y, Allen E, Ding J, Wang W: Giant axonal neuropathy. Cell Mol Life Sci: CMLS 2007, 64:601-609. (Pubitemid 46712461)
17. Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M, Hirohashi S: Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 2008, 135:1358-1368. 1368 e1351-1354.
18. Friedman JS, Ray JW, Waseem N, Johnson K, Brooks MJ, Hugosson T, Breuer D, Branham KE, Krauth DS, Bowne SJ, Sullivan LS, Ponjavic V, Gränse L, Khanna R, Trager EH, Gieser LM, Hughbanks-Wheaton D, Cojocaru RI, Ghiasvand NM, Chakarova CF, Abrahamson M, Göring HH, Webster AR, Birch DG, Abecasis GR, Fann Y, Bhattacharya SS, Daiger SP, Heckenlively JR, Andréasson S, et al: Mutations in a BTB-Kelch protein, KLHL7, cause autosomal-dominant retinitis pigmentosa. Am J Hum Genet 2009, 84:792-800.
19. Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, Pylypenko O, Beaurain G, Bonnefond A, Sand O, Simian C, Vidal-Petiot E, Soukaseum C, Mandet C, Broux F, Chabre O, Delahousse M, Esnault V, Fiquet B, Houillier P, Bagnis CI, Koenig J, Konrad M, Landais P, Mourani C, Niaudet P, Probst V, Thauvin C, Unwin RJ, Soroka SD, Ehret G, et al: KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet 2012, 44:456-460. S451-453.
20. MyHits. [http://myhits.isb-sib.ch]
21. National Center for Biotechnology Information (NCBI). [http://www.ncbi.nlm.nih.gov/protein]
22. European Bioinformatics Institute (EBI). [http:/www.ebi.ac.uk/Tools/msa/ clustalo]
23. Bioinformatics Services. [http://www.ebi.ac.uk/Tools/phylogeny/clustalw2- phylogeny]
24. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y: An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997, 236:313-322. (Pubitemid 27373291)
25. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M: Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999, 13:76-86. (Pubitemid 29045117)
26. Motohashi H, Yamamoto M: Carcinogenesis and transcriptional regulation through Maf recognition elements. Cancer Sci 2007, 98:135-139. (Pubitemid 44941863)
27. Kobayashi M, Itoh K, Suzuki T, Osanai H, Nishikawa K, Katoh Y, Takagi Y, Yamamoto M: Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system. Genes Cells 2002, 7:807-820. (Pubitemid 34947084)
28. Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, Igarashi K, Yamamoto M: Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004, 24:7130-7139. (Pubitemid 39014439)
29. Furukawa M, Xiong Y: BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol 2005, 25:162-171. (Pubitemid 40039808)
30. McMahon M, Itoh K, Yamamoto M, Hayes JD: Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 2003, 278:21592-21600. (Pubitemid 36792558)
31. Watai Y, Kobayashi A, Nagase H, Mizukami M, McEvoy J, Singer JD, Itoh K, Yamamoto M: Subcellular localization and cytoplasmic complex status of endogenous Keap1. Genes Cells 2007, 12:1163-1178. (Pubitemid 47500530)
32. Lo SC, Hannink M: PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex. J Biol Chem 2006, 281:37893-37903. (Pubitemid 46042093)
33. Mitsuishi Y, Motohashi H, Yamamoto M: The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Frontiers in oncology 2012, 2:200.
34. Padmanabhan B, Tong KI, Ohta T, Nakamura Y, Scharlock M, Ohtsuji M, Kang MI, Kobayashi A, Yokoyama S, Yamamoto M: Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell 2006, 21:689-700. (Pubitemid 43290735)
35. Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, Herman JG, Baylin SB, Sidransky D, Gabrielson E, Brock MV, Biswal S: Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 2006, 3:e420.
36. Soltysik-Espanola M, Rogers RA, Jiang S, Kim TA, Gaedigk R, White RA, Avraham H, Avraham S: Characterization of Mayven, a novel actin-binding protein predominantly expressed in brain. Mol Biol Cell 1999, 10:2361-2375. (Pubitemid 29343140)
37. Williams SK, Spence HJ, Rodgers RR, Ozanne BW, Fitzgerald U, Barnett SC: Role of Mayven, a kelch-related protein in oligodendrocyte process formation. J Neurosci Res 2005, 81:622-631. (Pubitemid 41532158)
38. Jiang S, Avraham HK, Park SY, Kim TA, Bu X, Seng S, Avraham S: Process elongation of oligodendrocytes is promoted by the Kelch-related actin-binding protein Mayven. J Neurochem 2005, 92:1191-1203. (Pubitemid 40344309)
39. Montague P, Kennedy PG, Barnett SC: Subcellular localization of Mayven following expression of wild type and mutant EGFP tagged cDNAs. BMC Neurosci 2010, 11:63.
40. Korutla L, Wang P, Jackson TG, Mackler SA: NAC1, a POZ/BTB protein that functions as a corepressor. Neurochem Int 2009, 54:245-252.
41. Tseng LA, Bixby JL: Interaction of an intracellular pentraxin with a BTB-Kelch protein is associated with ubiquitylation, aggregation and neuronal apoptosis. Mol Cell Neurosci 2011, 47:254-264.
42. Hugosson T, Friedman JS, Ponjavic V, Abrahamson M, Swaroop A, Andréasson S: Phenotype associated with mutation in the recently identified autosomal dominant retinitis pigmentosa KLHL7 gene. Arch Ophthalmol 2010, 128:772-778.
43. Wen Y, Locke KG, Klein M, Bowne SJ, Sullivan LS, Ray JW, Daiger SP, Birch DG, Hughbanks-Wheaton DK: Phenotypic characterization of 3 families with autosomal dominant retinitis pigmentosa due to mutations in KLHL7. Arch Ophthalmol 2011, 129:1475-1482.
44. Kigoshi Y, Tsuruta F, Chiba T: Ubiquitin ligase activity of Cul3-KLHL7 protein is attenuated by autosomal dominant retinitis pigmentosa causative mutation. J Biol Chem 2011, 286:33613-33621.
45. Uchida K, Akita Y, Matsuo K, Fujiwara S, Nakagawa A, Kazaoka Y, Hachiya H, Naganawa Y, Oh-Iwa I, Ohura K, Saga S, Kawai T, Matsumoto Y, Shimozato K, Kozaki K: Identification of specific autoantigens in Sjogren's syndrome by SEREX. Immunology 2005, 116:53-63. (Pubitemid 41208352)
46. Cirak S, von Deimling F, Sachdev S, Errington WJ, Herrmann R, Bönnemann C, Brockmann K, Hinderlich S, Lindner TH, Steinbrecher A, Hoffmann K, Privé GG, Hannink M, Nürnberg P, Voit T: Kelch-like homologue 9 mutation is associated with an early onset autosomal dominant distal myopathy. Brain 2010, 133:2123-2135.
47. Xu M, Da YW, Liu L, Wang F, Jia JP: Giant axonal neuropathy caused by a novel compound heterozygous mutation in the gigaxonin gene. J Child Neurol 2012. doi:10.1177/0883073812467688.
48. Kroll J, Shi X, Caprioli A, Liu HH, Waskow C, Lin KM, Miyazaki T, Rodewald HR, Sato TN: The BTB-kelch protein KLHL6 is involved in B-lymphocyte antigen receptor signaling and germinal center formation. Mol Cell Biol 2005, 25:8531-8540. (Pubitemid 41369174)
49. Puente XS, Pinyol M, Quesada V, Conde L, Ordóñez GR, Villamor N, Escaramis G, Jares P, Beà S, González-Díaz M, Bassaganyas L, Baumann T, Juan M, López-Guerra M, Colomer D, Tubío JM, López C, Navarro A, Tornador C, Aymerich M, Rozman M, Hernández JM, Puente DA, Freije JM, Velasco G, Gutiérrez- Fernández A, Costa D, Carrió A, Guijarro S, Enjuanes A, et al: Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011, 475:101-105.
50. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, Suzuki T, Kobayashi A, Yokota J, Sakiyama T, Shibata T, Yamamoto M, Hirohashi S: Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 2008, 68:1303-1309. (Pubitemid 351346836)
51. Yuan WC, Lee YR, Huang SF, Lin YM, Chen TY, Chung HC, Tsai CH, Chen HY, Chiang CT, Lai CK, Lu LT, Chen CH, Gu DL, Pu YS, Jou YS, Lu KP, Hsiao PW, Shih HM, Chen RH: A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression. Cancer Cell 2011, 20:214-228.
52. Tian H, Zhang B, Di J, Jiang G, Chen F, Li H, Li L, Pei D, Zheng J: Keap1: one stone kills three birds Nrf2, IKKbeta and Bcl-2/Bcl-xL. Cancer Lett 2012, 325:26-34.